Tau

Tau 詳細

英語名Microtubule-associated protein tau市販薬剤の数1
治験薬の数45ターゲットの別称MAPT,MTBT1,Paired helical filament-tau,MAPTL,Microtubule Associated Protein Tau,G Protein Beta1/Gamma2 Subunit-Interacting Factor 1,Protein Phosphatase 1, Regulatory Subunit 103,Neurofibrillary Tangle Protein,PHF-Tau,TAU,Microtubule-Associated Protein Tau, Isoform 4,Microtubule-Associated Protein Tau,PPP1R103,FTDP-17,MTBT2,DDPAC,MSTD,PPND,tau Proteins,MGC138549,FLJ31424
研究&開発段階Approved
英語名Microtubule-associated protein tau
ターゲットの別称MAPT,MTBT1,Paired helical filament-tau,MAPTL,Microtubule Associated Protein Tau,G Protein Beta1/Gamma2 Subunit-Interacting Factor 1,Protein Phosphatase 1, Regulatory Subunit 103,Neurofibrillary Tangle Protein,PHF-Tau,TAU,Microtubule-Associated Protein Tau, Isoform 4,Microtubule-Associated Protein Tau,PPP1R103,FTDP-17,MTBT2,DDPAC,MSTD,PPND,tau Proteins,MGC138549,FLJ31424
市販薬剤の数1
治験薬の数45
研究&開発段階Approved

Tauバックグランド

Tau is a microtubule-associated protein, which encodes by the MAPT gene that located on chromosome 17q21. Tau Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. Hyperphosphorylation of the tau protein (tau inclusions, pTau) can result in the self-assembly of tangles of paired helical filaments and straight filaments, which are involved in the pathogenesis of Alzheimer's disease, frontotemporal dementia, and other tauopathies.

Tau分子の別称

DDPAC,FTDP-17,MAPT,MSTD,MTBT1,Tau,PHF-tau,TAU

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BuntanetapANVS-405; ANVS-401Phase 3 ClinicalRaptor PharmaceuticalAlzheimer Disease; Chronic Traumatic Encephalopathy; Cognitive Dysfunction; Down Syndrome; Frontotemporal Dementia; Parkinson Disease
詳細
FlorzolotauF0-PBB3; PM-PBB3; [18F]APN-1607; [18F]MNI-958; APN-0000455; [18F]PM-PBB3; APN-1607; 18F-PM-PBB3; 18F-APN-1607Phase 3 ClinicalAprinoia Therapeutics LtdAlzheimer Disease; Cognition Disorders; Cognitive Dysfunction; Diagnostic agents; Nerve Degeneration; Supranuclear Palsy, Progressive
詳細
EtalanetugE-2814Phase 3 ClinicalEisai Co LtdAlzheimer Disease; Dementia
詳細
Izaflortaucipir F-18PI-2620; 18F-PI-2620; [18F]PI-2620Phase 3 ClinicalAc Immune Sa, PiramalAlzheimer Disease; Brain Injuries, Traumatic; Cognitive Dysfunction; Frontotemporal Lobar Degeneration; Opioid-Related Disorders; Parkinson Disease; Supranuclear Palsy, Progressive
詳細
[F-18]Flornaptitril[F-18]FDDNP; F-18-FNT-PETPhase 3 ClinicalUniversity Of California At Los AngelesAlzheimer Disease; Chronic Traumatic Encephalopathy
詳細
XTR-006XTR-006Phase 3 ClinicalBeijing Xiantong International Technology Co LtdAlzheimer Disease; Tauopathies
詳細
ZagotenemabLY-3303560Phase 2 ClinicalEli Lilly And CompanyAlzheimer Disease
詳細
PosdinemabJNJ-3657; JNJ-63733657Phase 2 ClinicalJohnson & Johnson Innovative MedicineAlzheimer Disease; Cognitive Dysfunction; Dementia
詳細
[18F]GTP-1[18F]GTP-1Phase 2 ClinicalGenentech IncAlzheimer Disease
詳細
[18F]THK-5105[18F]THK-5105Phase 2 ClinicalTohoku UniversityAlzheimer Disease
詳細
ISIS-814907BIIB-080; ISIS-814907; IONIS-MAPTRx; ISIS-BIIB4Rx; IONIS-BIIB4RXPhase 2 ClinicalBiogen Inc, Ionis Pharmaceuticals IncAlzheimer Disease; Cognitive Dysfunction
詳細
TilavonemabC2N-8E12; ABBV-8E12Phase 2 ClinicalC2n Diagnostics LlcAlzheimer Disease; Supranuclear Palsy, Progressive
詳細
Alzheimer's disease vaccine (Axon Neuroscience)AADvac-1Phase 2 ClinicalAxon BiochemicalsAlzheimer Disease; Primary Progressive Nonfluent Aphasia; Supranuclear Palsy, Progressive
詳細
SemorinemabMTAU-9937A; MTAU9937A; RG-6100; RO7105705; RO-7105705Phase 2 ClinicalAc Immune SaAlzheimer Disease
詳細
APN-1701[18F]AM-PBB3; 18F-AM-PBB3; APN-1701Phase 2 ClinicalAprinoia Therapeutics Ltd, National Institute Of Radiological SciencesAlzheimer Disease; Nerve Degeneration
詳細
VY-TAU-01VY-TAU01; VY-TAU-01; VY-7523Phase 2 ClinicalVoyager Therapeutics IncAlzheimer Disease
詳細
Anti-tau antibody (Prothena)BMS-986446; PRX-005Phase 2 ClinicalProthenaAlzheimer Disease; Frontotemporal Dementia
詳細
MK-2214MK-2214Phase 2 ClinicalMerck Sharp & Dohme LLCAlzheimer Disease
詳細
BEY-2153BEY-2153Phase 2 ClinicalBeyondbio IncAlzheimer Disease
詳細
BepranemabUCB-0107; RG6416Phase 2 ClinicalUcbAlzheimer Disease; Supranuclear Palsy, Progressive
詳細
[18F]THK-5117[18F]THK-5117Phase 2 ClinicalTohoku UniversityAlzheimer Disease
詳細
PNT-001PNT-001Phase 1 ClinicalBeth Israel Deaconess Medical CenterAlzheimer Disease; Brain Injuries, Traumatic
詳細
ReS19-TReS19-TPhase 1 ClinicalRemyndAlzheimer Disease
詳細
Mecripyrine HydrochlorideSCR-1693; Y-1A; Y-1Phase 1 ClinicalJiangsu Simcere Pharmaceutical Co Ltd, NeuroDawn Pharmaceutical Co Ltd, Yantai Yene Pharma Co LtdAlzheimer Disease; Brain Neoplasms
詳細
Lu-AF87908Lu-AF87908; Lu-AF-87908Phase 1 ClinicalH. Lundbeck A/SAlzheimer Disease
詳細
RDC-5RDC-5Phase 1 ClinicalChronos Therapeutics LtdAmyotrophic Lateral Sclerosis
詳細
MC-1 (Lilly)MC-1 (Lilly)Phase 1 ClinicalEli Lilly And CompanyAlzheimer Disease
詳細
OLX-07010OLX07010Phase 1 ClinicalOligomerix IncAlzheimer Disease; Dementia; Neurodegenerative Diseases; Supranuclear Palsy, Progressive
詳細
ProtollinPhase 1 ClinicalThe Brigham and Women's HospitalAlzheimer Disease
詳細
NB-02NB-02; DA-9803Phase 1 ClinicalDong-A ST Co LtdAlzheimer Disease; Lymphoma, Non-Hodgkin
詳細
MAPT siRNA therapeutic (Eli Lilly and Company)Phase 1 ClinicalEli Lilly And CompanyNeurodegenerative Diseases
詳細
18F-JSS20-183A18F-JSS20-183APhase 1 ClinicalUniversity Of PennsylvaniaTauopathies
詳細
ATC-102ATC-102; ATC102Phase 1 ClinicalAutotac Bio IncAlzheimer Disease
詳細
AB-19 (AUTOTAC Bio)AB-19 (AUTOTAC Bio)Phase 1 ClinicalAutotac Bio IncSupranuclear Palsy, Progressive
詳細
AB-12 po (AUTOTAC Bio)AB-12 poPhase 1 ClinicalAutotac Bio IncAlzheimer Disease
詳細
DNL-628OTV:MAPT; DNL-628Phase 1 ClinicalDenali Therapeutics IncAlzheimer Disease
詳細
[89Zr]Zr-DFO-BIIB080[89Zr]Zr-DFO; [89Zr]Zr-DFO-ISIS-814907Phase 1 ClinicalBiogen Inc
詳細
DA-7503DA-7503Phase 1 ClinicalDong-A ST Co Ltd
詳細
LY-3954068LY3954068; LY-3954068Phase 1 ClinicalEli Lilly And CompanyAlzheimer Disease
詳細
AS-603S-603; AS-603; AS-S603Phase 1 ClinicalAmyloid Solution IncAlzheimer Disease
詳細
ADEL-Y01ADEL-Y01Phase 1 ClinicalADEL Inc, Oscotec IncAlzheimer Disease; Tauopathies
詳細
APNmAb-005APNmAb-005Phase 1 ClinicalAprinoia Therapeutics LtdAlzheimer Disease; Nerve Degeneration; Tauopathies
詳細
AV-1959R/AV-1980R1959R + 1980R; AV 1959R + AV 1980RPhase 1 ClinicalNuravaxAlzheimer Disease
詳細
NIO-752NIO-752Phase 1 ClinicalNovartis Pharma AgAlzheimer Disease; Cognitive Dysfunction; Neurodegenerative Diseases; Supranuclear Palsy, Progressive
詳細
11C-PBB311C-PBB3ClinicalNational Institute Of Radiological SciencesAlzheimer Disease
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Flortaucipir F1818F-AV-1451; T807; F-18-AV-1451; [18F]-T-807; [3H]AV 1451; [F-18]T807; [F18]AV1451; LY3191748ApprovedSiemens Medical SolutionTauvidUnited StatesAlzheimer DiseaseAvid Radiopharmaceuticals Inc2020-05-28Alzheimer Disease; Aphasia, Primary Progressive; Brain Concussion; Brain Injuries; Brain Injuries, Traumatic; Chronic Traumatic Encephalopathy; Cognition Disorders; Cognitive Dysfunction; Corticobasal degeneration; Dementia; Depression; Diagnostic agents; Frontotemporal Dementia; Neurodegenerative Diseases; Parkinson Disease; Pick Disease of the Brain; Supranuclear Palsy, Progressive; Tauopathies
詳細

レビュー

  • P***g2021-08-24
    5評価
    I have purchased multiple antigens from ACRO for discovery projects and I have found that the quality of antigens purchased from Acro is great!! Acro has become by go to vendor when I am looking for quality antigens. In addition, Acro also provides an impressive range of formats for each antigens, including different tags. Not to mention, their customer service team is fantastic. Overall, a great company to work with.
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8